January 28, 2025

A groundbreaking study has revealed that weight-loss surgery can dramatically lower the risk of life-threatening complications in patients suffering from both cirrhosis and obesity. ... Read More

The U.S. Food and Drug Administration (FDA) has approved Spravato (esketamine) CIII, a revolutionary nasal spray designed to help individuals battling treatment-resistant depression (TRD). ... Read More